← Evidence map

ArticleCardiology and therapy2026

Study Design and Baseline Characteristics of the VERINA Study: Phase IV Evidence of Vericiguat for Worsening Heart Failure Management.

Jabir Abdulakutty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Study Design and Baseline Characteristics of the VERINA Study: Phase IV Evidence of Vericiguat for Worsening Heart Failure Management. | OpenQuestion